Mild hyponatremia is associated with functional and cognitive decline in chronic hemodialysis patients

Clinical Nephrology

Volumn 82, Issue 5, 2014, Pages 313-319

  Shavit, Linda ^a   Mikeladze, Inga ^a   Torem, Carmit ^a   Slotki, Itzchak ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

Chronic hemodialysis; Cognitive decline; Functional status; Hyponatremia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; CALCIUM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PARATHYROID HORMONE; PHOSPHORUS; SERUM ALBUMIN; SODIUM;

AGED; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CALCIUM BLOOD LEVEL; CHRONIC PAIN; COGNITIVE DEFECT; CONGESTIVE HEART FAILURE; DAILY LIFE ACTIVITY; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; FUNCTIONAL DISEASE; FUNCTIONAL STATUS; GERIATRIC DEPRESSION SCALE; HEART MUSCLE ISCHEMIA; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPONATREMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PREVALENCE; PROSPECTIVE STUDY; PRURITUS; RISK FACTOR; SLEEP DISORDER; SODIUM BLOOD LEVEL; SURVIVOR; TASK PERFORMANCE; WEIGHT GAIN; ADULT; CHRONIC DISEASE; COGNITION DISORDERS; COMPLICATION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; RENAL INSUFFICIENCY, CHRONIC; RENAL REPLACEMENT THERAPY; VERY ELDERLY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COGNITION DISORDERS; FEMALE; HUMANS; HYPONATREMIA; MALE; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84909579828     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108335     Document Type: Article

References (29)

1. Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis Assoc Disord. 2006; 20 (Suppl 2): S42-S46.
2. Posner HB, Tang MX, Luchsinger J, Lantigua R, Stern Y, Mayeux R. The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology. 2002; 58: 1175-1181.
3. Knopman D, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern P, Folsom AR; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001; 56: 42-48.
4. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol. 2004; 61: 661-666.
5. Solomon A, Kåreholt I, Ngandu T, Wolozin B, Macdonald SW, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M. Serum total cholesterol, statins and cognition in non-demented elderly. Neurobiol Aging. 2009; 30: 1006-1009.
6. Barberger-Gateau P, Raffaitin C, Letenneur L, Berr C, Tzourio C, Dartigues JF, Alpérovitch A. Dietary patterns and risk of dementia: the Three-City cohort study. Neurology. 2007; 69: 1921-1930.
7. Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr Opin Psychiatry. 2007; 20: 380-385.
8. Shaffi K, Tighiouart H, Scott T, Lou K, Drew D, Weiner D, Sarnak M. Low 25-hydroxyvitamin D levels and cognitive impairment in hemodialysis patients. Clin J Am Soc Nephrol. 2013; 8: 979-986.
9. United States Renal Data System. USRDS. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006. 2006 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States.
10. Seshadri S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D'Agostino RB, Wilson PW, Wolf PA. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002; 346: 476-483.
11. Savazzi GM, Cusmano F, Vinci S, Allegri L. Progression of cerebral atrophy in patients on regular hemodialysis treatment: long-term follow-up with cerebral computed tomography. Nephron. 1995; 69: 29-33.
12. Neto JF, Ferraz MB, Cendoroglo M, Draibe S, Yu L, Sesso R. Quality of life at the initiation of maintenance dialysis treatment - a comparison between the SF-36 and the KDQ questionnaires. Qual Life Res. 2000; 9: 101-107.
13. Seidel UK, Gronewold J, Volsek M, Todica O, Kribben A, Bruck H, Hermann DM. The prevalence, severity, and association with HbA1c and fibrinogen of cognitive impairment in chronic kidney disease. Kidney Int. 2014; 85: 693-702.
14. Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins. Lancet. 2004; 363: 1139-1146.
15. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psychiatry. 1987; 48: 314-318.
16. Yeudall LT, Reddon JR, Gill DM, Stefanyk WO. Normative data for the Halstead-Reitan neuropsychological tests stratified by age and sex. J Clin Psychol. 1987; 43: 346-367.
17. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW. Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA. 1963; 185: 914-919.
18. Kurella M, Chertow GM, Luan J, Yaffe K. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc. 2004; 52: 1863-1869.
19. Murray AM, Tupper DE, Knopman DS, Gilbertson DT, Pederson SL, Li S, Smith GE, Hochhalter AK, Collins AJ, Kane RL. Cognitive impairment in hemodialysis patients is common. Neurology. 2006; 67: 216-223.
20. Mizumasa T, Hirakata H, Yoshimitsu T, Hirakata E, Kubo M, Kashiwagi M, Tanaka H, Kanai H, Fujimi S, Iida M. Dialysis-related hypotension as a cause of progressive frontal lobe atrophy in chronic hemodialysis patients: a 3-year prospective study. Nephron Clin Pract. 2004; 97: c23-c30.
21. Radic J, Ljutic D, Radic M, Kovacic V, DodigCurkovic K, Šain M. Kidney transplantation improves cognitive and psychomotor functions in adult hemodialysis patients. Am J Nephrol. 2011; 34: 399-406.
22. Harciarek M, Biedunkiewicz B, Lichodziejewska-Niemierko M, Debska-Slizien A, Rutkowski B. Continuous cognitive improvement 1 year following successful kidney transplant. Kidney Int. 2011; 79: 1353-1360.
23. Nigwekar SU, Wenger J, Thadhani R, Bhan I. Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis. 2013; 62: 755-762.
24. Waikar SS, Curhan GC, Brunelli SM. Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med. 2011; 124: 77-84.
25. Hoorn EJ, Zietse R. Hyponatremia and mortality: moving beyond associations. Am J Kidney Dis. 2013; 62: 139-149.
26. Moissl U, Arias-Guillén M, Wabel P, Fontseré N, Carrera M, Campistol JM, Maduell F. Bioimpedance-guided fluid management in hemodialysis patients. Clin J Am Soc Nephrol. 2013; 8: 1575-1582.
27. Zoccali C, Torino C, Tripepi R, Tripepi G, D'Arrigo G, Postorino M, Gargani L, Sicari R, Picano E, Mallamaci F, Lung US; Lung US in CKD Working Group. Pulmonary congestion predicts cardiac events and mortality in ESRD. J Am Soc Nephrol. 2013; 24: 639-646.
28. Ayus JC, Negri AL, Kalantar-Zadeh K, Moritz ML. Is chronic hyponatremia a novel risk factor for hip fracture in the elderly? Nephrol Dial Transplant. 2012; 27: 3725-3731.
29. Gunathilake R, Oldmeadow C, McEvoy M, Kelly B, Inder K, Schofield P, Attia J. Mild hyponatremia is associated with impaired cognition and falls in community-dwelling older persons. J Am Geriatr Soc. 2013; 61: 1838-1839.